Khasraw, M., Ameratunga, M., Lassman, A. B., Ashley, D. M., Wheeler, H., & Pavlakis, N. (2014). A meta-analysis of antiangiogenic therapy for glioblastoma (GBM). In Journal of Clinical Oncology (Vol. 32, pp. 2047–2047). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.2047

Khasraw, Mustafa, Malaka Ameratunga, Andrew B. Lassman, David M. Ashley, Helen Wheeler, and Nick Pavlakis. “A meta-analysis of antiangiogenic therapy for glioblastoma (GBM).” In Journal of Clinical Oncology, 32:2047–2047. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.2047.

Khasraw M, Ameratunga M, Lassman AB, Ashley DM, Wheeler H, Pavlakis N. A meta-analysis of antiangiogenic therapy for glioblastoma (GBM). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 2047–2047.

Khasraw, Mustafa, et al. “A meta-analysis of antiangiogenic therapy for glioblastoma (GBM).” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 2047–2047. Crossref, doi:10.1200/jco.2014.32.15_suppl.2047.

Khasraw M, Ameratunga M, Lassman AB, Ashley DM, Wheeler H, Pavlakis N. A meta-analysis of antiangiogenic therapy for glioblastoma (GBM). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 2047–2047.